Evidence map›Paper›PMID 23411111›Full record

ReviewReproductive toxicology (Elmsford, N.Y.)2013

Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology.

Laura N Vandenberg, Theo Colborn, Tyrone B Hayes, Jerrold J Heindel, David R Jacobs, Duk-Hee Lee, John Peterson Myers, Toshi Shioda, Ana M Soto, Frederick S vom Saal and 2 more

Abstract readReview
In one paragraph

Review in Reproductive toxicology (Elmsford, N.Y.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Endocrine Disruptor Chemicals and Children's Health.International journal of molecular sciences · 2023
    Review
  15. Article
  16. Article
  17. Perfluorooctanoic Acid Disrupts Ovarian Steroidogenesis and Folliculogenesis in Adult Mice.Toxicological sciences : an official journal of the Society of Toxicology · 2022
    Article
  18. Article
  19. Article
  20. Combined Effects of Different Endocrine-Disrupting Chemicals (EDCs) on Prostate Gland.International journal of environmental research and public health · 2021
    Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Laura N VandenbergCenter for Regenerative & Developmental Biology, and Department of Biology, Tufts University, Medford, MA, United States. laura.vandenberg@tufts.edu
Theo Colborn
Tyrone B Hayes
Jerrold J Heindel
David R Jacobs
Duk-Hee Lee
John Peterson Myers
Toshi Shioda
Ana M Soto
Frederick S vom Saal
Wade V Welshons
R Thomas Zoeller

Funding

EPIDEMIOLOGY: OXIDATIVE STRESS AND EARLY ATHEROSCLEROSISR01HL053560 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI GROSS, MYRON D, JACOBS, DAVID R · 1995 to 2014
$9.0M
Mechanisms of developmental toxicity of Bisphenol-AR01ES008314 · NIEHS · TUFTS UNIVERSITY BOSTON · PI SOTO, ANA · 1996 to 2016
$6.8M
PCB Disruption of Thyroid Hormone Action During DevelopmentR01ES010026 · NIEHS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI ZOELLER, ROBERT THOMAS · 2000 to 2013
$3.8M
Bisphenol A: Urine flow disorder and prostate pathologyRC2ES018764 · NIEHS · UNIVERSITY OF MISSOURI-COLUMBIA · PI RICKE, WILLIAM A, VOM SAAL, FREDERICK S · 2009 to 2010
$1.1M
Epidemiology: Oxidative Stress and Early AtherosclerosisR56HL053560 · NHLBI · UNIVERSITY OF MINNESOTA · PI JACOBS, DAVID R · 2009 to 2009
$494k
PCB Disruption of Thyroid Hormone Action during DevelopmentR56ES010026 · NIEHS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI ZOELLER, ROBERT THOMAS · 2007 to 2007
$387k
Bioelectrical controls of left-right asymmetryF32GM087107 · NIGMS · TUFTS UNIVERSITY MEDFORD · PI VANDENBERG, LAURA N. · 2009 to 2010
$98k
NHLBI NIH HHS HL 53560NHLBI NIH HHS R01 HL053560NHLBI NIH HHS R56 HL053560NIEHS NIH HHS ES 010026NIEHS NIH HHS ES 018764NIEHS NIH HHS ES 08314NIEHS NIH HHS R01 ES008314NIEHS NIH HHS R01 ES010026NIEHS NIH HHS R56 ES010026NIEHS NIH HHS RC2 ES018764NIGMS NIH HHS F32 GM087107NIGMS NIH HHS GM 087107
6 · The paper itself

Abstract

For years, scientists from various disciplines have studied the effects of endocrine disrupting chemicals (EDCs) on the health and wellbeing of humans and wildlife. Some studies have specifically focused on the effects of low doses, i.e. those in the range that are thought to be safe for humans and/or animals. Others have focused on the existence of non-monotonic dose-response curves. These concepts challenge the way that chemical risk assessment is performed for EDCs. Continued discussions have clarified exactly what controversies and challenges remain. We address several of these issues, including why the study and regulation of EDCs should incorporate endocrine principles; what level of consensus there is for low dose effects; challenges to our understanding of non-monotonicity; and whether EDCs have been demonstrated to produce adverse effects. This discussion should result in a better understanding of these issues, and allow for additional dialog on their impact on risk assessment.

Indexed as

AnimalsDecision MakingDose-Response Relationship, DrugEndocrine DisruptorsEndocrinologyEnvironmental PollutantsGovernment RegulationHumansRisk AssessmentEndocrine DisruptorsEnvironmental Pollutants

Identifiers

PMID23411111
PMCPMC3902067

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.